AUG 02, 2018 6:00 AM PDT

Chronic Infections Outsmart the Immune System

WRITTEN BY: Caitlin Williams

Many chronic infections evade the immune system’s defenses so that it can remain comfortably in the host mooching off our bodies. A recent study in Cell Reports looked at how the parasite that causes visceral leishmaniasis, also known as kala-azar or black fever, escapes the host’s defenses. Visceral leishmaniasis, a potentially lethal chronic disease, is the second leading cause of death by parasitic infection. It is caused by the Leishmania species of protozoan parasite and transmitted to humans by the bites of female sandflies. In 2015 the World Health Organization (WHO) reported 300,000 estimated annual cases with over 20,000 deaths each year due to visceral leishmaniasis. Of these cases, 90% were reported to occur in six countries: Bangladesh, Brazil, Ethiopia, India, South Sudan and Sudan. Onset can be chronic or acute, with incubation of weeks to months, and it affects internal organs such as the spleen, liver, and bone marrow.

High power image of nuclei with amastigote forms of Leishmaniasis. Source: Calicut Medical COllege

Interferon-gamma, or type II interferon, is a cytokine essential to innate and adaptive immunity against infections. Interferon-gamma has immunostimulatory and immunomodulatory effects and is produced by natural killer cells in the innate response and T cells CD4 and CD8 during the adaptive immune response. During visceral leishmaniasis, CD4 T cells expressing interferon-gamma appear later in infection and in smaller numbers than expected, but the recent study by Dr. Simona Stager’s team at the Institute National de la Recherche Scientifique (INRS) has shown that the lack of T cells is due to the protective cells dying. To further study this phenomenon they looked at previously identified transcription factors, proteins that modulate the activity of one or more genes, that were present but unusual for CD4 T cells. The specific transcription factor detected, IRF-5, is known for its role in innate immunity but not CD4 T cells.

The study of IRF-5 showed that it leads CD4 cells to self-destruct due to tissue destruction. Previously unknown signals in CD4 cells are activated when tissue is destroyed, causing them to die following a series of reactions that are not fully understood. The mechanism behind this signaling begins with Toll-like Receptor 7 (TLR7), which is usually activated in innate immune cells when a pathogen is recognized. During chronic inflammation cellular residues present after tissue destruction activates TLR7 in CD4 cells. This activation leads to expression of IRF-5, which then increases expression of Death Receptor 5 (DR5) and caspase 8, which leads to cell death. The white blood cells involved in the attack are eliminated by the biological process of the host and not the parasite, allowing the parasite to be protected and sustain a chronic infection.

This mechanism may play a role with other diseases that lead to chronic infection and inflammation. The newly discovered link between chronic inflammation induction of CD4 T cell death by the TLR7 and IRF-5 pathways could lead to new treatment options. A better understanding of this work and the cellular activity induced by IRF-5 in immune cells could reveal new therapeutic targets for visceral leishmaniasis and other chronic inflammatory diseases.

To learn more about leishmaniasis watch the video below!

World Health Organization, Center for Disease Control

About the Author
  • Caitlin holds a doctorate degree in Microbiology from the University of Georgia where she studied Mycoplasma pneumoniae and its glycan receptors. She received her Bachelor's in Biology from Virginia Tech (GO HOKIES!). She has a passion for science communication and STEM education with a goal to improve science literacy. She enjoys topics related to human health, with a particular soft spot for pathogens.
You May Also Like
JUL 07, 2020
Immunology
Existing drugs can prevent SARS-CoV-2 from hijacking cells
JUL 07, 2020
Existing drugs can prevent SARS-CoV-2 from hijacking cells
An international team of researchers has analysed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins i ...
JUL 17, 2020
Drug Discovery & Development
Could Low-Dose Radiation Therapy Treat COVID-19?
JUL 17, 2020
Could Low-Dose Radiation Therapy Treat COVID-19?
Research from a century ago points towards the potential of low-dose radiation therapy (LDRT) for treating pneumonia. Ev ...
AUG 05, 2020
Coronavirus
Age-old Immune Components Affecting COVID-19 Severity
AUG 05, 2020
Age-old Immune Components Affecting COVID-19 Severity
One of the most unsettling aspects of the coronavirus pandemic is the wide range of severity those affected seem to expe ...
AUG 27, 2020
Immunology
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
AUG 27, 2020
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
  Living medicines in the form of stem cell therapies have immense potential for their ability to regenerate and he ...
SEP 07, 2020
Immunology
CRISPR Pumps the Brakes on the Immune System to Support Gene Therapies
SEP 07, 2020
CRISPR Pumps the Brakes on the Immune System to Support Gene Therapies
The ability to edit the human genome using CRISPR has been heralded as a revolution in medicine. However, one of the big ...
OCT 21, 2020
Drug Discovery & Development
Experimental Vaccine Shows Promise in Halting Alzheimer's
OCT 21, 2020
Experimental Vaccine Shows Promise in Halting Alzheimer's
In a preclinical study, researchers from the Univerity of South Florida have found that a vaccine that targets neurotoxi ...
Loading Comments...